Key result
Adherence to the ABC pathway in clinically complex patients with atrial fibrillation reduced the risk of all-cause death by 28% compared to non-adherence.
Why the study?
Clinical complexity is increasingly prevalent in AF, but limited data exist regarding the usefulness of the Atrial fibrillation Better Care (ABC) pathway in clinically complex patients.
Does adherence to the ABC pathway reduce the risk of major adverse events in clinically complex patients with atrial fibrillation?
Observational (n=9,966)
Yes
Does adherence to the ABC pathway reduce the risk of major adverse events in clinically complex patients with atrial fibrillation?
Adherence to the holistic ABC pathway significantly improves survival and reduces cardiovascular events in clinically complex patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
ABC adherence was associated with fewer deaths and MACEs in complex AF; leaves open whether implementation improves outcomes pending trials.
BACKGROUND: Clinical complexity is increasingly prevalent among patients with atrial fibrillation (AF). The 'Atrial fibrillation Better Care' (ABC) pathway approach has been proposed to streamline a more holistic and integrated approach to AF care; however, there are limited data on its usefulness among clinically complex patients. We aim to determine the impact of ABC pathway in a contemporary cohort of clinically complex AF patients. METHODS: From the ESC-EHRA EORP-AF General Long-Term Registry, we analysed clinically complex AF patients, defined as the presence of frailty, multimorbidity and/or polypharmacy. A K-medoids cluster analysis was performed to identify different groups of clinical complexity. The impact of an ABC-adherent approach on major outcomes was analysed through Cox-regression analyses and delay of event (DoE) analyses. RESULTS: Among 9966 AF patients included, 8289 (83.1%) were clinically complex. Adherence to the ABC pathway in the clinically complex group reduced the risk of all-cause death (adjusted HR [aHR]: 0.72, 95%CI 0.58-0.91), major adverse cardiovascular events (MACEs; aHR: 0.68, 95%CI 0.52-0.87) and composite outcome (aHR: 0.70, 95%CI: 0.58-0.85). Adherence to the ABC pathway was associated with a significant reduction in the risk of death (aHR: 0.74, 95%CI 0.56-0.98) and composite outcome (aHR: 0.76, 95%CI 0.60-0.96) also in the high-complexity cluster; similar trends were observed for MACEs. In DoE analyses, an ABC-adherent approach resulted in significant gains in event-free survival for all the outcomes investigated in clinically complex patients. Based on absolute risk reduction at 1 year of follow-up, the number needed to treat for ABC pathway adherence was 24 for all-cause death, 31 for MACEs and 20 for the composite outcome. CONCLUSIONS: An ABC-adherent approach reduces the risk of major outcomes in clinically complex AF patients. Ensuring adherence to the ABC pathway is essential to improve clinical outcomes among clinically complex AF patients.
No takes yet. Share an insight, caveat, or question.
Romiti et al. (2022) conducted an observational in Atrial fibrillation (n=9,966). Adherence to the Atrial fibrillation Better Care (ABC) pathway vs. Non-adherence to the ABC pathway was evaluated on All-cause death (aHR 0.72, 95% CI 0.58-0.91). Adherence to the ABC pathway in clinically complex patients with atrial fibrillation reduced the risk of all-cause death by 28% compared to non-adherence.
Synapse has enriched 10 related papers. Consider them for comparative context: